IGF1 and hepatocellular carcinoma: They found that lower plasma IGF-1 and higher plasma VEGF levels significantly correlated with advanced end-stage liver disease and HCC clinicopathologic parameters and poor overall survival; with cut-off values of 26 ng/mL and 450 pg/mL, respectively.